Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Antisense and RNAi Therapeutics Market Outlook

The global antisense and rNAi therapeutics market size attained a value of USD 1.86 billion in 2023 driven by intensive study of gene functioning for disease management, through the use of malfunctioning gene and controlling its gene expression. The market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032 to attain a value of USD 3.87 billion by 2032.

Global Antisense and RNAi Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

Antisense and RNAi therapeutics make particular and highly effective gene silencing possible. Antisense technology offers a chance to manipulate the expression of gene and thus, it is regarded as an efficient therapy for targeting ribonucleic acids (RNA). It is widely used for oncology, cardiovascular diseases, respiratory disorders, renal diseases, neurodegenerative disorders, genetic disorders, infectious diseases, and others.

Global Antisense and RNAi Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Antisense and RNAi therapeutics industry can be further divided based on:

  • Technology
    • RNA interference
    • SiRNA
    • MiRNA
    • Antisense RNA 
  • Route of Administration
    • Pulmonary Delivery
    • Intravenous Injections
    • Intra-dermal Injections
    • Intraperitoneal Injections
    • Topical Delivery

The EMR report looks into the regional antisense and RNAi therapeutics markets like the North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.

Market Analysis

The global antisense and RNAi therapeutics industry is being driven by intensive study of gene functioning for disease management, through the use of malfunctioning gene and controlling its gene expression. The market is further driven by various collaborations taking place between pharmaceutical companies and contract research organisations, working to enhance drug delivery.

Global Antisense and RNAi Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global antisense and RNAi therapeutics industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • OliX Pharmaceuticals Inc.
  • Sanofi S.A, SAN (EPA)
  • GlaxoSmithKline, GSK (LON)
  • Ionis Pharmaceuticals 
  • Benitec Biopharma Ltd 
  • Silence Therapeutics Plc 

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Indication
  • Route of Administration
  • End User
  • Region
Breakup by Technology
  • RNA Interference
  • siRNA
  • miRNA
  • Antisense RNA
Breakup by Indication
  • Oncology
  • Cardiovascular Disease
  • Respiratory Disorders
  • Renal Disease
  • Neurodegenerative Disorders
  • Genetic Disorders
  • Infectious Disease
  • Others
Breakup by Route of Administration
  • Pulmonary Delivery
  • Intravenous Injections
  • Intra-dermal Injections
  • Intraperitoneal Injections
  • Topical Delivery
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Other
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • OliX Pharmaceuticals, Inc.
  • Sanofi S.A. SAN (EPA)
  • GlaxoSmithKline Plc GSK (LON)
  • Ionis Pharmaceuticals, Inc.
  • Benitec Biopharma Inc.,
  • Silence Therapeutics Plc
  • Astellas Pharma Inc.
  • Alnylam Pharmaceuticals, Inc.
  • MEDLINE INDUSTRIES
  • Dicerna Pharmaceuticals
  • Tekmira Pharmaceuticals
  • Cenix BioScience
  • Sirnaomics
  • Arrowhead Pharmaceuticals

Antisense and RNAi Therapeutics Market Report Snapshots

Antisense and RNAi Therapeutics Market Size

Antisense and RNAi Therapeutics Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

Globally, antisense and RNAi therapeutics market reached a value of USD 1.86 billion in 2023.

The market is projected to expand at a CAGR of 8.5% from 2024 to 2032, growing to USD 3.87 billion by 2032.

The major industry drivers are intensive study of gene functioning for disease management, through the use of malfunctioning gene, and controlling its gene expression.

The key trends in the market are various collaborations taking place between pharmaceutical companies and contract research organisations, working to enhance drug delivery.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The technology types include RNA interference, siRNA, miRNA, and antisense RNA.

The application sectors include oncology, cardiovascular diseases, respiratory disorders, renal diseases, neurodegenerative disorders, genetic disorders, and infectious diseases, among others.

The routes of administration include pulmonary delivery, intravenous injections, intra-dermal injections, intraperitoneal injections, and topical delivery, among others.

The major players in the industry are OliX Pharmaceuticals Inc., Sanofi S.A, SAN (EPA), GlaxoSmithKline, GSK (LON), Ionis Pharmaceutical, Benitec Biopharma Ltd, Silence Therapeutics Plc, Others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124